Medicine & Life Sciences

1. Neoplasms 100%
2. Non-Small Cell Lung Carcinoma 43%
3. Weight Loss 43%
4. Drug Therapy 41%
5. Survival 40%
6. Anorexia 38%
7. Ovarian Neoplasms 36%
8. Esophageal Neoplasms 28%
9. Therapeutics 27%
10. Cachexia 27%
11. Clinical Trials 26%
12. Hiccup 24%
13. Appetite 23%
14. ErbB Receptors 23%
15. Lung Neoplasms 23%
16. Exanthema 22%
17. Quality of Life 21%
18. Breast Neoplasms 21%
19. Paclitaxel 19%
20. Pancreatic Neoplasms 17%
21. Health Personnel 17%
22. Elderly 16%
23. Carboplatin 16%
24. Cancer Survivors 15%
25. Small Cell Lung Carcinoma 14%
26. Adjuvant Chemotherapy 14%
27. Confidence Intervals 13%
28. Placebos 13%
29. Adenocarcinoma 13%
30. Esophagogastric Junction 12%
31. Capecitabine 11%
32. Palliative Care 11%
33. Radiation 10%
34. Megestrol Acetate 10%
35. Systematic Reviews 10%
36. Muscles 10%
37. Fatigue 10%
38. Oncologists 9%
39. Bevacizumab 9%
40. Incidence 9%
41. Pemetrexed 8%
42. Complementary Therapies 8%
43. Weights and Measures 8%
44. protein kinase C lambda 8%
45. Poly(ADP-ribose) Polymerase Inhibitors 8%
46. Amifostine 8%
47. National Cancer Institute (U.S.) 7%
48. Skeletal Muscle 7%
49. Skin 7%